Publications
Journal of autoimmunityDec 2023 |
142
103152
DOI:
10.1016/j.jaut.2023.103152

Loss of function of XBP1 splicing activity of IRE1α favors B cell tolerance breakdown

Reuschlé, Quentin; Van Heddegem, Laurien; Bosteels, Victor; Moncan, Matthieu; Depauw, Sabine; Wadier, Nadège; Maréchal, Sandra; De Nolf, Clint; Delgado, Virginia; Messai, Yosra; Stolzenberg, Marie-Claude; Magérus, Aude; Werck, Angélique; Olagne, Jérôme; Li, Quan; Lefevre, Guillaume; Korganow, Anne-Sophie; Rieux-Laucat, Frédéric; Janssens, Sophie; Soulas-Sprauel, Pauline
Abstract
Anti-nuclear antibodies are the hallmark of autoimmune diseases such as systemic lupus erythematosus (SLE) and scleroderma. However, the molecular mechanisms of B cell tolerance breakdown in these pathological contexts are poorly known. The study of rare familial forms of autoimmune diseases could therefore help to better describe common biological mechanisms leading to B cell tolerance breakdown. By Whole-Exome Sequencing, we identified a new heterozygous mutation (p.R594C) in ERN1 gene, encoding IRE1α (Inositol-Requiring Enzyme 1α), in a multiplex family with several members presenting autoantibody-mediated autoimmunity. Using human cell lines and a knock-in (KI) transgenic mouse model, we showed that this mutation led to a profound defect of IRE1α ribonuclease activity on X-Box Binding Protein 1 (XBP1) splicing. The KI mice developed a broad panel of autoantibodies, however in a subclinical manner. These results suggest that a decrease of spliced form of XBP1 (XBP1s) production could contribute to B cell tolerance breakdown and give new insights into the function of IRE1α which are important to consider for the development of IRE1α targeting strategies.

Related Publications